Keyphrases
Transforming Growth Factor-β
100%
Fibrosis
75%
Skeletal muscle
75%
Skeletal muscle Atrophy
59%
Angiotensin-(1-7)
54%
Oxidative Stress
53%
Endothelial Cells
50%
Sarcopenia
43%
Angiotensin II (Ang II)
41%
Skeletal muscle Cells
36%
Mas Receptor
36%
Muscle Strength
36%
Endotoxin
32%
Sepsis
29%
Bile Acids
27%
Renin-angiotensin System
27%
Reactive Oxygen Species
24%
Chronic Liver Disease
24%
Muscular Dystrophy
22%
Endotoxemia
22%
Fibroblasts
21%
Myoblast
21%
Ubiquitin-proteasome System
21%
TRPM7
20%
Duchenne muscular Dystrophy
20%
Skeletal muscle Wasting
20%
Muscle Mass
20%
Myotubes
20%
Deoxycholic Acid
19%
Cholic Acid
19%
Non-alcoholic Fatty Liver Disease (NAFLD)
19%
NF-B
19%
Mdx Mice
18%
Connective Tissue Growth Factor
18%
Pathological Conditions
18%
Protein Level
18%
Myosin Heavy Chain (MyHC)
18%
Muscle Wasting
18%
Decorin
17%
CCN2
17%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
16%
Myonuclear Apoptosis
16%
Transforming Growth factor-β1 (TGF-β1)
16%
TGR5
16%
Fibrotic Response
15%
Vascular Endothelial Cells
15%
Atrogin-1
15%
Molecular Mechanism
15%
MuRF1
15%
Oxidase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
83%
Muscle Atrophy
77%
Mouse
76%
Fibrosis
65%
angiotensin[1-7]
59%
Reactive Oxygen Metabolite
35%
Transforming Growth Factor Beta
35%
Angiotensin II
35%
Transforming Growth Factor
33%
Sarcopenia
33%
Sepsis
28%
Endotoxin
28%
Inflammation
27%
Angiotensin
27%
Chronic Liver Disease
25%
Muscular Dystrophy
25%
Bile Acid
24%
Endotoxemia
22%
Connective Tissue Growth Factor
21%
Lipopolysaccharide
19%
High Density Lipoprotein
19%
Myosin Heavy Chain
18%
Renin
18%
Duchenne Muscular Dystrophy
16%
Disease
15%
Cytokine
15%
Nonalcoholic Fatty Liver
15%
Fibrinogen
14%
Ion Channel
14%
Oxidoreductase
14%
Andrographolide
14%
Deoxycholic Acid
14%
Somatomedin C
13%
Endothelial Dysfunction
13%
Transforming Growth Factor Beta1
11%
Atrogin 1
11%
Ubiquitin
11%
Proteasome
11%
TGF-Beta
10%
Multiple Organ Failure
10%
Hypotension
10%
Transforming Growth Factor Beta Receptor 1
10%
Muscle Disease
9%
Transient Receptor Potential Channel M4
9%
Cholic Acid
9%
Growth Hormone
9%
Inflammatory Disease
8%
Calcium Ion
8%
Calcium Channel
8%
Combination Therapy
7%
Medicine and Dentistry
Skeletal Muscle
69%
Fibrosis
54%
Endothelial Cell
42%
Oxidative Stress
41%
Muscle Atrophy
32%
Sarcopenia
30%
Endotoxin
27%
Reactive Oxygen Species
26%
Transforming Growth Factor Beta
25%
Angiotensin II
24%
Muscular Dystrophy
24%
Skeletal Muscle Atrophy
24%
Sepsis
22%
Fibroblast
20%
Transforming Growth Factor
19%
Receptor Potential
19%
Nonalcoholic Fatty Liver
19%
Oxidoreductase
18%
Programmed Cell Death
17%
Muscle Strength
17%
Signal Transduction
17%
Chronic Liver Disease
17%
Receptor
16%
Vascular Endothelial Cell
14%
Disease
14%
Lipopolysaccharide
14%
Renin Angiotensin Aldosterone System
13%
Endotoxemia
13%
Connective Tissue Growth Factor
12%
Duchenne Muscular Dystrophy
11%
Cell Therapy
11%
Hypotension
10%
Transforming Growth Factor Beta Receptor 1
10%
Skeletal Muscle Cell
10%
Myotube
9%
Bile Acid
9%
High-Density Lipoprotein
9%
Lipid Diet
9%
Fibrinogen
9%
Disseminated Intravascular Coagulation
9%
Muscle Regeneration
9%
Gene Expression
9%
Transient Receptor Potential Channel M4
9%
Cell Migration
9%
Protein Expression
8%
Serositis
8%
Ubiquitin
8%
Somatomedin C
8%
Proteasome
8%
Ion Channel
8%